Croscarmellose sodium

From WikiMD's Food, Medicine & Wellnesspedia

Croscarmellose Sodium is a sodium salt derived from carboxymethyl cellulose. It is widely used as a disintegrant in pharmaceutical formulations, enabling tablets or capsules to disintegrate in the presence of moisture and thereby facilitating the release of the active ingredients for absorption. Due to its critical role in the effectiveness of oral dosage forms, croscarmellose sodium is considered an essential excipient in the pharmaceutical industry.

Properties and Mechanism of Action[edit | edit source]

Croscarmellose sodium is characterized by its high swelling capacity and excellent water absorption abilities. It functions by rapidly swelling in contact with fluids, which leads to an increase in the volume of the tablet or capsule, creating enough pressure to break it apart. This action enhances the dissolution rate of the active pharmaceutical ingredients (APIs) in the gastrointestinal tract, improving bioavailability and ensuring the medication can exert its therapeutic effect more efficiently.

Applications[edit | edit source]

The primary application of croscarmellose sodium is in the formulation of solid oral dosage forms such as tablets and capsules. It is particularly useful in products that are designed to disintegrate in the oral cavity, known as orally disintegrating tablets (ODTs), as well as in formulations that require rapid onset of action. Besides its use in the pharmaceutical sector, croscarmellose sodium is also employed in dietary supplements and some food products as a disintegrant or anti-caking agent.

Regulatory Status[edit | edit source]

As an excipient, croscarmellose sodium is regulated by various health authorities worldwide. In the United States, it is recognized as Generally Recognized As Safe (GRAS) by the Food and Drug Administration (FDA) when used in accordance with Good Manufacturing Practices (GMP). Similarly, it is approved for use in the European Union and other regions, subject to compliance with respective regulatory standards for pharmaceutical excipients.

Safety and Side Effects[edit | edit source]

Croscarmellose sodium is generally considered safe for use in pharmaceutical and food products. However, like all excipients, it may cause adverse reactions in sensitive individuals. Reported side effects are rare but can include gastrointestinal disturbances such as bloating, gas, and mild diarrhea. It is advisable for individuals with known allergies to cellulose-based substances to consult healthcare professionals before using products containing croscarmellose sodium.

Manufacturing[edit | edit source]

The production of croscarmellose sodium involves the chemical modification of cellulose, specifically through the introduction of carboxymethyl groups. This modification enhances the cellulose's hydrophilicity and disintegration properties, making it suitable for use as a pharmaceutical excipient. Manufacturers of croscarmellose sodium must adhere to stringent quality control and GMP to ensure the safety and efficacy of the final product.

Conclusion[edit | edit source]

Croscarmellose sodium plays a pivotal role in the pharmaceutical industry as a disintegrant in oral dosage forms. Its ability to rapidly absorb water and swell ensures the efficient disintegration of tablets and capsules, facilitating the release and absorption of active ingredients. While it is generally safe for use, awareness of potential side effects is important for individuals with sensitivities to cellulose-derived substances.

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD